Recombinant DNA viral vector for transfecting animal cells

Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

4352401, 4352402, 4353201, 43524021, 514 44, 424 9321, A61K 4800, C12N 1500

Patent

active

058174923

ABSTRACT:
An animal cell is co-transfected with both a recombinant DNA viral vector which bears a promoter, a recombinase gene and a poly(A) sequence and a recombinant DNA viral vector which bears two recombinase-recognizing sequences and which further bears an origin of replication, a promoter, a foreign gene and a poly(A) sequence, each of which is located between the two recombinase-recognizing sequences. Thereafter, in the co-transfected animal cell, a DNA fragment containing the origin of replication, promoter, foreign gene and poly(A) sequence is excised from the vector by the action of a recombinase expressed in the another vector. The DNA fragment forms a circular DNA molecule which autonomously replicates in the co-transfected animal cell due to the origin of replication, whereby the foreign gene is continuously expressed. Accordingly, the combination of the above two DNA viral vectors wherein a gene which is defective in patients is used as the foreign gene is quite useful especially for the treatment of the patient with hereditary diseases.

REFERENCES:
Proceedings of the National Academy of Sciences of USA, vol. 84, No. 24, 1 Dec. 1987, pp. 9108-9112, XPo02002088 Sauer, B. et al: "Site-Specific Insertion of DNA Into a Pseudorabies Virus Vector".
Journal of Virology, vol. 66, No. 9, 1 Sep. 1992, pp. 5509-5515, XP000568386 Gage P.J. et al: "A Cell-free Recombination System for Site-Specific Integration of Multigenic Shuttle Plasmids Into the Herpes Simplex Virus Type 1 Genome".
Mollecular and Cellular Biology, vol. 13, No. 2, Feb. 1993, Washington US, pp. 918-927, XP00202619, Wang, Q. & Taylor, M.W.: "Correction of a deletion mutant by gene targeting with an adenovirus vector".
Nucleic Acids Research, vol. 23, No. 19, 11 Oct. 1995, pp. 3816-3821, XP002011774 Kanegae, Y. et al: "Efficient Gene Activation in Mammalian Cells by using Recombinant Adenovirus Expressing Site-Specific CRE Recombinase".
Fukushige et al., PNAS, 89, 1992, 7905-7909.
Sauer et al., Nuc. Acids Res., 17(1), 1989, 147-160.
Hodgson, Exp. Opin. Ther. Pat., 5(5), 1995, 459-468.
Culver et al., TIG, 10(5), 1994, 174-178.
Miller et al., FASEB Journal, 9, 1995, 190-199.
Marshall, Science, 269, 1995, 1050-1055.
NIH, "Report and Recommendations . . . ", Orkin et al. Dec. 7, 1995, 1-40.
Niwa et al, "Efficient Selection for High-Expression Transfectants with a Novel Eukaryotic Vector," Gene, 108, pp. 193-200 (1991).
Engelhardt et al, "Direct Gene Transfer of Human CTFR Into Human Bronchial Epithelia of Xenografts with El-Deleted Adenoviruses,"0 Nature Genetics, vol. 4, pp. 27-34 (May 1993).
Saito et al, "Adenovirus Vector," The 41st General Meeting: The Society of Japanese Virologists (1993).
Kanegae et al "Adenovirus Vector and Gene Therapy," Experimental Medicine, vol. 12, No. 3 (1994).
Kanegae et al, Experimental Medicine Supplemental Volume, Biomanual Series 4, pp. 43-58 (1994).
Kanegae et al., "Efficient Gene Activation . . . Recombinase,"Nucleic Acids Research, vol. 23, No. 19, pp. 3816-3821 (1995).
Bergemann et al., "Excision of Specific DNA . . . Recombination," Nucleic Acids Research, vol. 23, No. 21, pp. 4451-4456 (1995).
The 43rd Annual Meeting of the Society of Japanese Virologists, (Sep. 29, 1995), 2016, p.126.
Science, vol. 265, Jul. 1, 1994, pp. 103-106, Hua Gu et al, "Deletion of a DNA Polymerase .beta. Gene Segment in T Cells Using Cell Type-Specific Gene Targeting".
Journal of Virology, Aug. 1995, pp. 4600-4606, Martina Anton et al, "Site-Specific Recombination Mediated by an Adenovirus Vector Expressing the Cre Recombinase Protein: a Molecular . . . Expression".
The First Annual Meeting 1995, Japanese Society of Gene Therapy, May 21, 1995, Yumi Kanagae et al, "Application of Cre/loxP Sysem to Adenovirus Vector".
The Second Brain Tumor Gene Therapy Meeting, Feb. 3 and 4, 1995, "Adenovirus Vector".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Recombinant DNA viral vector for transfecting animal cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant DNA viral vector for transfecting animal cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant DNA viral vector for transfecting animal cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-76031

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.